Myriad在同意出售产前健康检测业务后股价大涨

路透中文
Yesterday
BUZZ-Myriad在同意出售产前健康检测业务后股价大涨

10月20日 - ** 基因检测公司Myriad Genetics(MYGN.O)的股价在盘前交易中上涨20.7%,至5.05美元

** 该公司表示,将以2.1亿美元现金外加库存价值,将其产前健康检测业务出售给Labcorp(LH.N)

** MYGN表示,该交易预计将促进Myriad的营收增长和盈利能力,同时增强其资产负债表的稳健性

** Labcorp预计该交易将在第一年带来约1.6亿美元的收入

** Myriad的产前检测产品组合包含多款专为妊娠和生殖健康设计的基因筛查产品

** 截至上次收盘,MYGN股价年内累计下跌31%

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10